4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-003346
Chief Executive Officer sold 12,035 shares at an average $1.83 ($21,993)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-21 | Sale | −9,346 | $1.81 | $16,927 | 883,964 | D |
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-22 | Sale | −2,689 | $1.88 | $5,066 | 881,275 | D |
| Open-market sales · 12,035 sh · avg $1.83 · $21,993 | |||||||
Loading xslF345X05/wk-form4_1769209845.xml…